TrialNeuro-oncology2006

A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.

Michael D Prados et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.